The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
J

Present & Future of Targeted Therapy for Advanced CRC: IO for dMMR/MSI-H Disease, RAS/BRAF Mutations, AMG510, Encorafenib+Binimetinib+Cetuximab, T-DXd for HER2+ mCRC

By The Asian Oncology Society 1st Virtual International Conference FEATURING Jin Li
By The Asian Oncology Society 1st Virtual International Conference FEATURING Jin Li
204 views
February 18, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Gastrointestinal
18:54
The Asian Oncology Society 1st Virtual International Conference

Genomic Era of CRC Surgery: Total Mesorectal Excision, CME & CVL…

Feat. S. Lee
50:29
The Asian Oncology Society 1st Virtual International Conference

Biomarker Driven and Targeted Therapies in CRC: dMMR/MSI-H, HER2 Ove…

Feat. H. Lenz
16:45
The Asian Oncology Society 1st Virtual International Conference

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR v…

Feat. M. Choi
14:13
The Asian Oncology Society 1st Virtual International Conference

IO in Advanced HCC: Can We Achieve Better ORR With 1L Nivo+Ipi? Does…

Feat. M. Choi
14:19
The Asian Oncology Society 1st Virtual International Conference

NGS for Pancreatobiliary Cancer: Maintenance Olaparib Data in Germli…

Feat. M. Choi
22:56
The Asian Oncology Society 1st Virtual International Conference

Managing Gastric Cancer: Can Genetic Analysis and NGS Help? Should W…

Feat. K. Yoshida
11:02
The Asian Oncology Society 1st Virtual International Conference

Present & Future of Targeted Therapy for Advanced CRC: IO for dM…

Feat. J. Li